Funabashi, Japan

Yukohiro Shigeta

This inventor holds 2 USPTO granted patents. Top assignee: Nissan Chemical Industries Limited. Active years: 2010-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yukohiro Shigeta. Retrieved from https://idiyas.com/inventor/yukohiro-shigeta

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2010-2011

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Yukohiro Shigeta

Introduction

Yukohiro Shigeta is a notable inventor based in Funabashi, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-arrhythmic agents. With a total of 2 patents to his name, Shigeta's work has the potential to impact medical treatments significantly.

Latest Patents

Shigeta's latest patents include a tricyclic benzopyrane compound. This invention relates to benzopyran derivatives that can be utilized as anti-arrhythmic agents. The compounds are characterized by specific formulas that include various functional groups and structural features, making them valuable in pharmaceutical applications.

Career Highlights

Yukohiro Shigeta is associated with Nissan Chemical Industries Limited, where he has been able to apply his innovative ideas in a corporate setting. His work focuses on creating compounds that can improve health outcomes, particularly in the area of heart rhythm disorders.

Collaborations

Shigeta has collaborated with notable coworkers such as Osamu Uesugi and Tomoyuki Matsuda. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Yukohiro Shigeta's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…